An AllTrials project

NCT07548632: An ongoing trial by Oculis

This trial is ongoing. It must report results 1 year, 1 month from now.

Full data

Full entry on ClinicalTrials.gov NCT07548632
Title A Phase 2b/3, Double-masked, Randomized, Vehicle-controlled, Multicenter Study Evaluating Licaminlimab in Dry Eye Disease Patients With a Specific TNFR1 Genotype
Results Status Ongoing
ACT or pACT? This is what FDAAA officially calls an "Applicable Clinical Trial"
Start date April 16, 2026
Completion date Dec. 31, 2026
Required reporting date Dec. 31, 2027, midnight
Actual reporting date None
Date last checked at ClinicalTrials.gov Nov. 20, 2026
Days late None